Yes, plasma-derived AT is used in Japan to treat sepsis. On-label. That’s the reason for the seemingly odd declarative statement in the Japanese paper we’ve been discussing.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”